Navigation Links
Leading Life Sciences Luminaries Connect at Innovation Ireland Reception

WASHINGTON, June 28, 2011 /PRNewswire/ -- Innovation Ireland ( tonight will host an event at the Embassy of Ireland in Washington, D.C., to coincide with the showcase of Ireland's world class biotechnology industry at BIO's 8th annual World Congress on Industrial Biotechnology and Bioprocessing.

The event will be hosted by Innovation Ireland and The Irish Ambassador to the United States, Michael Collins. It will bring together a large Irish-American network of business, science and investment leaders across the US, including key executives from the Irish and US commercial and research communities, the business and employer federation, IBEC, the Irish Office of the Chief Scientist and other leading members of the Irish Diaspora.

Brian O'Neill, Director of Life Sciences at Enterprise Ireland and speaker at the event, said, "The biopharmaceutical sector is a real powerhouse of the Irish economy. We now have end-to-end capabilities from world-class research facilities as well as highly innovative Irish technology companies and leading global manufacturers. The cohesion of great minds at events like the BIO conference is paramount to Ireland's rapidly growing presence and reputation in the biotechnology industry. "

Ireland's life sciences industry exports $63b per annum and employs some 50,000 people. As a testament to Ireland's track record in supporting innovation, it has secured more than $5 billion in investments from leading life sciences companies in recent years such as Allergan, Bristol–Myers Squibb, Genzyme, Gilead, Centocor, Merck, Wyeth, Pfizer and Schering-Plough.  These foreign investments, as well as a growing domestic sector, are supported by a high level of government funding through Science Foundation Ireland, IDA Ireland and Enterprise Ireland.

About Innovation Ireland

Ireland's inward investment promotion agency, IDA Ireland ( partners with foreign investors, helping them to set up and develop their business in Ireland. Enterprise Ireland ( is responsible for supporting Irish businesses in the manufacturing and internationally traded service sectors. Science Foundation Ireland ( invests in academic researchers and research teams who are most likely to generate new knowledge, leading edge technologies and competitive enterprises in the fields of science and engineering.  The Irish BioIndustry Association ( is the leading representative body for the Biotechnology Industry in Ireland and aims to promote, support and encourage the further development of the multinational and indigenous biotech sector in Ireland.

SOURCE Enterprise Ireland
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Coventry Launches Market Leading Online Savings Account With Added Poppy Appeal
2. BioLife Solutions Now The Leading Supplier of Pre-Formulated GMP Cryopreservation Media for Umbilical Cord Blood Stem Cells
3. DATATRAK Recognized as 2011 Crains Leading EDGE Award Winner
4. Leading Ag Biotechnology Companies in Europe and America Save 50-80% of Field Study Management Time with eStudy
5. At This Years American Academy of AntiAging (A4M) Conference, Glycation and AGEs (Advanced Glycation End Products) Were Named the Leading Factors in Premature Aging and Disease
6. Dune Medicals MarginProbe™ Demonstrates Increased Positive Margin Identification Leading to Reduction in Patients Indicated for Re-excision in Landmark Lumpectomy Surgery Trial
7. Brain regions can take short naps during wakefulness, leading to errors
8. ERT Awarded over $10 Million of ePRO Business from Major Pharma - Increasing its Position as a Leading ePRO Provider
9. Reportlinker Adds The 2011 Top Ten Worlds Leading Life Science Intermediates Companies
10. Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market
11. RadQual, LLC Announces a New Industry Leading Dose Calibrator Reference Standard
Post Your Comments:
(Date:6/27/2016)... /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") ... shareholders, Clean Technology Fund I, LP and Clean Technology ... based venture capital funds which together hold approximately 59% ... diluted, as converted basis), that they have entered into ... holdings in Biorem to TUS Holdings Co. Ltd. ("TUS") ...
(Date:6/27/2016)... ... 27, 2016 , ... Parallel 6 , the leading software as a ... Reach Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine ... team. , Using the CONSULT module, patients and physicians can schedule a face to ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
Breaking Biology News(10 mins):